MedTrace Logo

Study to Compare the Diopsys NOVA and LKC RETeval Devices

NCT05416268 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-06-14

No results posted yet for this study

Summary

To compare the Diopsys NOVA and LKC RETeval Devices using the Diopsys Lid Electrodes and LKC RETeval Self-Adhering Electrode Arrays.

Conditions

  • Retinal Disease

Interventions

DIAGNOSTIC_TEST

Electroretinography

Two different electroretinogram devices (Diopsys NOVA and LKC RETeval Devices) will be evaluated with two different electrode arrays (Diopsys Lid Electrodes and LKC RETeval Self-Adhering Electrode Arrays).

Sponsors & Collaborators

  • Diopsys, Inc.

    lead INDUSTRY

Principal Investigators

  • Nate Lighthizer, OD · NSU Oklahoma College of Optometry

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-04
Primary Completion
2022-05-06
Completion
2022-05-06
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05416268 on ClinicalTrials.gov